NDC properties for "terbutaline sulfate 2.5 MG Oral Tablet" (RxCUI 857677)
About this data
The tables show NDC propoerties for terbutaline sulfate 2.5 MG Oral Tablet with the RxCUI 857677
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for terbutaline sulfate 2.5 MG Oral Tablet (RxCUI 857677)
| ANDA | ANDA075877 |
|---|---|
| ANDA | ANDA077152 |
| ANDA | ANDA211832 |
| MMSL_CODE | BD3287 |
| MMSL_CODE | CD3287 |
| RxCUI | 857677 |
| SNOMEDCT | 374625008 |
| SPL_SET_ID | 0a95bc4f-34d3-4b5e-841b-6839e1c1e0c7 |
| SPL_SET_ID | 352e3476-2bc4-4995-9fd9-4a8864417f1a |
| SPL_SET_ID | 382dcebb-6e41-4335-818d-b5822e3fb884 |
| SPL_SET_ID | 3a4e5046-293c-4616-8679-6da65f31626b |
| SPL_SET_ID | 4e400aef-05d0-2aea-e054-00144ff88e88 |
| SPL_SET_ID | 859267c6-3d14-4123-9b9d-4fc248f09726 |
| SPL_SET_ID | 879be756-991a-42c5-a381-9c8c2ad1fbdb |
| SPL_SET_ID | 94742710-e87e-4e1c-85ee-0a2e7a77f0de |
| SPL_SET_ID | d810a15b-3e10-4f6c-a36e-8ddecbaba9c3 |
| SPL_SET_ID | fbf54709-5857-4dbc-9233-ebd7abff88c8 |
| VUID | 4004614 |
| Prescribable Synonym | terbutaline sulfate 2.5 MG Oral Tablet |
| RXNAV_STR | terbutaline sulfate 2.5 MG Oral Tablet |
| RxNorm Name | terbutaline sulfate 2.5 MG Oral Tablet |
| Related queries | Interactions (for RxCUI 857677) |
NDC Properties
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| Packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | WHITE(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 448656 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 0115-2611 |
NDC Item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| Packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 0527-1318 |
NDC Item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| Packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 10135-579 |
NDC Item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| Packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| Packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 24979-132 |
NDC Item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| Packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 62135-524 |
NDC Item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| Packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
| Related queries | Properties for NDC 9 62559-721 |
NDC Item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| Packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
| Related queries | Properties for NDC 9 68084-256 |
NDC Item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| Packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| Packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| Packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| Packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |
NDC Item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| Packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
| Related queries | Properties for NDC 9 71205-938 |